Luyan Pharma Co.,Ltd. (002788.SZ)
CNY 8.76
(0.0%)
CNY 8.76
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 19.84 Billion | 19.46 Billion | 17.54 Billion | 15.53 Billion | 15 Billion | 11.5 Billion |
| Cost of Revenue | 18.33 Billion | 17.94 Billion | 16.17 Billion | 14.29 Billion | 13.83 Billion | 10.6 Billion |
| Gross Profit | 1.5 Billion | 1.51 Billion | 1.37 Billion | 1.23 Billion | 1.16 Billion | 899.9 Million |
| Operating Expenses | 1.03 Billion | 769.93 Million | 732.94 Million | 646.7 Million | 636.45 Million | 505.51 Million |
| Selling, General and Administrative Expenses | 763.94 Million | 480.1 Million | 422.45 Million | 380.3 Million | 364.93 Million | 256.81 Million |
| Research and Development Expenses | 5.53 Million | 4.14 Million | 2.97 Million | 3.86 Million | 5.18 Million | 2.64 Million |
| Other Expenses | 268.45 Million | 285.69 Million | 307.51 Million | 262.53 Million | 266.32 Million | -1.17 Million |
| Cost and Expenses | 19.37 Billion | 18.71 Billion | 16.9 Billion | 14.94 Billion | 14.47 Billion | 11.1 Billion |
| Operating Income | 468.55 Million | 740.43 Million | 645.08 Million | 589.09 Million | 547.01 Million | 260.93 Million |
| Interest Expense | 228.01 Million | 219.1 Million | 184.06 Million | 163.86 Million | 149.71 Million | 118.89 Million |
| Income Tax Expense | 104.92 Million | 115.03 Million | 110.6 Million | 104.31 Million | 86.56 Million | 75.18 Million |
| Earnings before Tax | 469.42 Million | 466.01 Million | 415.21 Million | 372.12 Million | 344.07 Million | 259.76 Million |
| Net Income | 363.53 Million | 345.15 Million | 305.87 Million | 266.62 Million | 255.88 Million | 180.32 Million |
| Earnings Per Share Basic | 0.94 | 0.89 | 0.79 | 0.69 | 0.73 | 0.51 |
| Earnings Per Share Diluted | 0.94 | 0.89 | 0.79 | 0.69 | 0.73 | 0.51 |
| Weighted Average Shares Outstanding | 386.73 Million | 388.51 Million | 388.51 Million | 388.51 Million | 351 Million | 351 Million |
| Weighted Average Shares Outstanding (Diluted) | 388.51 Million | 388.51 Million | 388.51 Million | 388.51 Million | 351 Million | 352.07 Million |
| Gross Margin | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
| EBIT Margin | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Profit Margin | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| EBITDA | 819.73 Million | 807.92 Million | 712.04 Million | 591.39 Million | 546.34 Million | 432.47 Million |
| Earnings Before Tax Margin | 0.02 | 0.04 | 0.04 | 0.04 | 0.04 | 0.02 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 5.1 Billion | 5.15 Billion | 5.13 Billion | 19.84 Billion | 5.07 Billion | 4.75 Billion |
| Cost of Revenue | 4.74 Billion | 4.8 Billion | 4.75 Billion | 18.33 Billion | 4.64 Billion | 4.4 Billion |
| Gross Profit | 360.95 Million | 348.94 Million | 378.15 Million | 1.5 Billion | 421.21 Million | 345.49 Million |
| Operating Expenses | 209.79 Million | 157.16 Million | 203.49 Million | 788.42 Million | 213.91 Million | 188.41 Million |
| Selling, General and Administrative Expenses | 517.46 Million | 156.63 Million | 192.83 Million | - | -59.7 Million | 310.13 Million |
| Research and Development Expenses | 897.71 Thousand | 1.51 Million | 1.21 Million | - | 2.69 Million | 896.99 Thousand |
| Other Expenses | -308.56 Million | 994.2 Thousand | 19.48 Thousand | 865.24 Thousand | 570.89 Thousand | -222.19 Thousand |
| Cost and Expenses | 4.95 Billion | 4.96 Billion | 4.96 Billion | 19.12 Billion | 4.86 Billion | 4.59 Billion |
| Operating Income | 91.97 Million | 191.77 Million | 105.52 Million | 468.55 Million | 146.1 Million | 89.96 Million |
| Interest Expense | 61.56 Million | 40.6 Million | 50.77 Million | 222.85 Million | 71.85 Million | 42.56 Million |
| Income Tax Expense | 21.51 Million | 32.37 Million | 22.01 Million | 104.92 Million | 41.24 Million | 20.77 Million |
| Earnings before Tax | 88.65 Million | 142.06 Million | 105.54 Million | 469.42 Million | 146.68 Million | 89.74 Million |
| Net Income | 66.97 Million | 106.59 Million | 83.77 Million | 363.53 Million | 101.55 Million | 72.96 Million |
| Earnings Per Share Basic | 0.17 | 0.27 | 0.22 | - | 0.26 | 0.19 |
| Earnings Per Share Diluted | 0.17 | 0.27 | 0.22 | - | 0.26 | 0.19 |
| Weighted Average Shares Outstanding | 388.51 Million | 388.51 Million | 380.8 Million | 386.73 Million | 388.51 Million | 388.51 Million |
| Weighted Average Shares Outstanding (Diluted) | 388.51 Million | 388.51 Million | 388.51 Million | 388.51 Million | 388.51 Million | 388.51 Million |
| Gross Margin | 0.07 | 0.07 | 0.07 | 0.08 | 0.08 | 0.07 |
| EBIT Margin | 0.03 | 0.04 | 0.03 | - | 0.04 | 0.03 |
| Profit Margin | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| EBITDA | 150.22 Million | 227.71 Million | 171.59 Million | - | 222.4 Million | 141.66 Million |
| Earnings Before Tax Margin | 0.02 | 0.04 | 0.02 | 0.02 | 0.03 | 0.02 |
5805
006360
DRH
0032
MODISONLTD
1251